Lv1
63 积分 2021-03-15 加入
药物性肝损伤的基因多态性研究进展
17天前
已完结
Consistent efficacy of efruxifermin across PNPLA3 genotypes in phase 2b trials in MASH
22天前
已关闭
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics
4个月前
已完结
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ‐1a Biologics to Inform Potential Utility in Biosimilar Development
4个月前
已完结
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics
4个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
8个月前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
8个月前
已完结
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
8个月前
已完结
Renal function and its association with retinal microcirculation and choroidal thickness in type 2 diabetes: Insights from cystatin C and creatinine
9个月前
已完结
皖公网安备34019202002308
